These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37620018)
1. Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs. Martin TW; LaRue SM; Griffin L; Leary D; Boss MK Vet Comp Oncol; 2023 Dec; 21(4):656-664. PubMed ID: 37620018 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma. Lee BI; LaRue SM; Seguin B; Griffin L; Prebble A; Martin T; Leary D; Boss MK Vet Comp Oncol; 2020 Dec; 18(4):843-853. PubMed ID: 32515526 [TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas. Lee BM; Clarke D; Watson M; Laver T Vet Comp Oncol; 2020 Dec; 18(4):590-598. PubMed ID: 32115867 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy. Altwal J; Lee BI; Boss MK; LaRue SM; Martin TW Vet Comp Oncol; 2024 Mar; 22(1):125-135. PubMed ID: 38246695 [TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases. Kruckman-Gatesy CR; Ames MK; Griffin LR; Boss MK; Rao S; Leary D; LaRue SM J Vet Cardiol; 2020 Feb; 27():62-77. PubMed ID: 32078943 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non-modulated hypofractionated radiation therapy. Trageser E; Martin T; Hoaglund E; Leary D; LaRue S; Boss MK Vet Comp Oncol; 2022 Jun; 20(2):491-501. PubMed ID: 34936172 [TBL] [Abstract][Full Text] [Related]
7. Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats. Reczynska AI; LaRue SM; Boss MK; Lee BI; Leary D; Pohlmann K; Griffin L; Lana S; Wormhoudt Martin T J Vet Intern Med; 2022 Mar; 36(2):733-742. PubMed ID: 35188694 [TBL] [Abstract][Full Text] [Related]
8. Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs. Martin TW; Griffin L; Custis J; Ryan SD; Lafferty M; Boss MK; Regan D; Rao S; Leary D; Withrow SJ; LaRue SM Vet Comp Oncol; 2021 Jun; 19(2):284-294. PubMed ID: 33403752 [TBL] [Abstract][Full Text] [Related]
9. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas. Fox-Alvarez S; Shiomitsu K; Lejeune AT; Szivek A; Kubicek L Vet Radiol Ultrasound; 2020 May; 61(3):370-378. PubMed ID: 32189433 [TBL] [Abstract][Full Text] [Related]
10. Canine primary liver tumors treated with stereotactic body radiation therapy: A case series. Chan QYP; Morrow D; Lurie D Vet Radiol Ultrasound; 2024 Mar; 65(2):121-129. PubMed ID: 38279767 [TBL] [Abstract][Full Text] [Related]
11. Response of Canine Soft Tissue Sarcoma to Stereotactic Body Radiotherapy. Tierce R; Martin T; Hughes KL; Harrison L; Swancutt KL; Rao S; Leary D; LaRue SM; Boss MK Radiat Res; 2021 Dec; 196(6):587-601. PubMed ID: 34473832 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs. Linder T; Wakamatsu C; Jacovino J; Hsieh YH; Mueller M Vet Comp Oncol; 2023 Mar; 21(1):45-53. PubMed ID: 36149359 [TBL] [Abstract][Full Text] [Related]
14. Canine salivary gland carcinoma treated with stereotactic body radiation therapy: a retrospective case series. Gualtieri P; Martin T; Leary D; Lana SE; LaRue SM; Boss MK Front Vet Sci; 2023; 10():1202265. PubMed ID: 37441554 [TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for heart-base tumors in six dogs. Magestro LM; Gieger TL; Nolan MW J Vet Cardiol; 2018 Jun; 20(3):186-197. PubMed ID: 29724584 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic characteristics, postoperative outcome, and prognostic factors in dogs with primary pulmonary carcinomas - A retrospective study of 61 dogs]. Plavec T; Žagar Ž; Kessler M Tierarztl Prax Ausg K Kleintiere Heimtiere; 2022 Oct; 50(5):317-328. PubMed ID: 36323269 [TBL] [Abstract][Full Text] [Related]
17. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors. Glasser SA; Charney S; Dervisis NG; Witten MR; Ettinger S; Berg J; Joseph R J Am Anim Hosp Assoc; 2014; 50(2):96-104. PubMed ID: 24446402 [TBL] [Abstract][Full Text] [Related]
18. Pilot study evaluating the feasibility of stereotactic body radiation therapy for canine anal sac adenocarcinomas. Swan M; Morrow D; Grace M; Adby N; Lurie D Vet Radiol Ultrasound; 2021 Sep; 62(5):621-629. PubMed ID: 34121267 [TBL] [Abstract][Full Text] [Related]
19. Radiation toxicity grading after chemoradiotherapy of canine urinary tract carcinomas: Comparing VRTOG to VRTOG_v2.0. Ahrens C; Beatrice L; Meier V; Rohrer Bley C Vet Comp Oncol; 2024 Jun; 22(2):255-264. PubMed ID: 38544415 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart-base tumours in dogs. Hansen KS; Théon AP; Willcox JL; Stern JA; Kent MS Vet Comp Oncol; 2021 Mar; 19(1):191-200. PubMed ID: 33135852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]